Coexistence of rheumatoid arthritis, myasthenia gravis, and pemphigus superficialis?
| Autor: | Vincenzo Ruocco, S. Migliaresi, V. Guerrera, Ada Lo Schiavo, Maria Luisa Lombardi |
|---|---|
| Přispěvatelé: | LO SCHIAVO, Ada, V., Guerrera, S., Migliaresi, M. L., Lombardi, V., Ruocco |
| Rok vydání: | 1995 |
| Předmět: |
Thymoma
integumentary system business.industry Penicillamine Human leukocyte antigen Dermatology medicine.disease Myasthenia gravis Histocompatibility Pemphigus Infectious Diseases immune system diseases Rheumatoid arthritis Immunology medicine skin and connective tissue diseases business Pemphigus foliaceus medicine.drug |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology. 5:191-194 |
| ISSN: | 1468-3083 0926-9959 |
| Popis: | d -Penicillamine (DP) is widely used nowadays in the treatment of rheumatoid arthritis, despite its well known side effects of an autoimmune nature, often associated with specific histocompatibility antigens (HLA). We report the case of a woman, suffering from rheumatoid arthritis (RA), treated with DP, who developed myasthenia gravis (MG) and pemphigus foliaceus (PF) and whose phenotype has only antigens usually associated with pemphigus. This may be the second published case of concurrent pemphigus and myasthenia gravis induced by d -penicillamine therapy, in the absence of thymoma. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text